Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation

British Journal of Pharmacology

Volumn 172, Issue 9, 2015, Pages 2330-2342

  Magalhaes G S ^a   Rodrigues Machado, M G ^a   Motta Santos, D ^a   Silva, A R ^a   Caliari, M V ^a   Prata, L O ^a   Abreu, S C ^b   Rocco, P R M ^b   Barcelos, L S ^a   Santos, R A S ^a   Campagnole Santos, M J ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN[1-7]; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MAS RECEPTOR; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; PLACEBO; RANTES; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ANTIINFLAMMATORY AGENT; AUTACOID; COLLAGEN; G PROTEIN COUPLED RECEPTOR; MAPK1 PROTEIN, MOUSE; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS MUSCLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INFUSION PUMP; LUNG ALVEOLUS EPITHELIUM; MALE; MORPHOMETRICS; MOUSE; MOUSE MODEL; NONHUMAN; OSMOTIC MINIPUMP; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROVOCATION TEST; RADIOIMMUNOASSAY; RESPIRATORY TRACT ALLERGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING; AGONISTS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HYPERTROPHY, RIGHT VENTRICULAR; LUNG; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; RESPIRATORY HYPERSENSITIVITY; SIGNAL TRANSDUCTION;

AIRWAY REMODELING; ANGIOTENSIN I; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; HYPERTROPHY, RIGHT VENTRICULAR; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; LUNG; MALE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OVALBUMIN; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PNEUMONIA; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY HYPERSENSITIVITY; SIGNAL TRANSDUCTION;

EID: 84926615759     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13057     Document Type: Article

References (55)

1. Alam R, Gorska MM, (2011). Mitogen-activated protein kinase signaling and ERK1/2 bistability in asthma. Clin Exp Allergy 41: 149-159.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The concise guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The concise guide to PHARMACOLOGY 2013/14: ion channels. Br J Pharmacol 170: 1607-1651.
4. Barnes PJ, (1998). Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 158: 123-132.
5. Bertagnolli M, Casali KR, De Souza FB, Rigatto K, Becker L, Santos S, et al. (2013). An orally active angiotensin-(1-7) inclusion compound and exercise training produce similar cardiovascular effects in spontaneously hypertensive rats. Peptides 51: 65-73.
6. Boyce JA, Bochner B, Finkelman FD, Rothenberg ME, (2012). Advances in mechanisms of asthma, allergy, and immunology in 2011. J Allergy Clin Immunol 129: 335-341.
7. Brown PJ, Greville HW, Finucane KE, (1984). Asthma and irreversible airflow obstruction. Thorax 39: 131-136.
8. Chien JW, Lin CY, Yang KD, Lin CH, Kao JK, Tsai YG, (2013). Increased IL-17A secreting CD4 (+) T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity. Clin Exp Allergy 43: 1018-1026.
9. Da Silveira KD, Coelho FM, Vieira AT, Sachs D, Barroso LC, Costa V, et al. (2010). Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol 185: 5569-5576.
10. Dandekar RD, Khan MM, (2012). Involvement of histamine receptors in SAPK/JNK phosphorylation. Int Immunopharmacol 13: 190-196.
11. El-Hashim AZ, Renno WM, Raghupathy R, Abduo HT, Akhtar S, Benter IF, (2012). Angiotensin-(1-7) inhibits allergic inflammation, via the Mas receptor, through suppression of ERK1/2- and NF-κB-dependent pathways. Br J Pharmacol 166: 1964-1976.
12. Fahy JV, (2009). Eosinophilic and neutrophilic inflammation in asthma insights from clinical studies. Proc Am Thorac Soc 6: 256-259.
13. Gamble J, Stevenson M, McClean E, Heaney LG, (2009). The prevalence of no adherence in difficult asthma. Am J Respir Crit Care Med 180: 817-822.
14. Georas SN, Guo J, De Fanis U, Casolaro V, (2005). T-helper cell type-2 regulation in allergic disease. Eur Respir J 26: 1119-1137.
15. Giani JF, Gironacci MM, Munoz MC, Turyn D, Dominici FP, (2008). Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity. Exp Physiol 93: 570-578.
16. Gironacci MM, Adamo HP, Corradi G, Santos RA, Ortiz P, Carretero OA, (2011). Angiotensin (1-7) induces MAS receptor internalization. Hypertension 58: 176-181.
17. Guimaraes PS, Santiago NM, Xavier CH, Velloso EP, Fontes MA, Santos RA, et al. (2012). Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats. Am J Physiol Heart Circ Physiol 303: 393-400.
18. Hirasawa N, Santini F, Beaven MA, (1995). Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line. Indications of different pathways for release of arachidonic acid and secretory granules. J Immunol 154: 5391-5402.
19. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
20. Kimata M, Inagaki N, Kato T, Miura T, Serizawa I, Nagai H, (2000). Roles of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells. Biochem Pharmacol 60: 589-594.
21. Klein N, Gembardt F, Supé S, Kaestle SM, Nickles H, Erfinanda L, et al. (2013). Angiotensin-(1-7) protects from experimental acute lung injury. Crit Care Med 41: 334-343.
22. Komai M, Tanaka H, Masuda T, Nagão K, Ishizaki M, Sawada M, et al. (2003). Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma. Br J Pharmacol 138: 912-920.
23. Lancas T, Kasahara D, Prado CM, Tiberio IF, Martins MA, Dolhnikoff M, (2006). Comparison of early and late responses to antigen of sensitized guinea pigs parenchymal lung strips. J Appl Physiol 100: 1610-1616.
24. Lassalle P, Gosset P, Delneste Y, Tsicopoulos A, Capron A, Joseph M, et al. (1993). Modulation of adhesion molecule expression on endothelial cells during the late asthmatic reaction: role of macrophage-derived tumour necrosis factor-alpha. Clin Exp Immunol 94: 105-110.
25. Lin TY, Venkatesan N, Nishioka M, Kyoh S, Al-Alwan L, Baglole CJ, et al. (2014). Monocyte-derived fibrocytes induce an inflammatory phenotype in airway smooth muscle cells. Clin Exp Allergy 44: 1347-1360.
26. Marques FD, Ferreira AJ, Sinisterra RD, Jacoby BA, Sousa FB, Caliari MV, et al. (2011). An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension 57: 477-483.
27. Mendes AC, Ferreira AJ, Pinheiro SV, Santos RA, (2005). Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats. Regul Pept 125: 29-34.
28. Myou S, Fujimura M, Kamio Y, Ishiura Y, Kurashima K, Tachibana H, et al. (2000). Effect of losartan, a type 1 angiotensin II receptor antagonist, on bronchial hyperresponsiveness to methacholine in patients with bronchial asthma. Am J Respir Crit Care Med 162: 40-44.
29. Myou S, Fujimura M, Kamio Y, Kita T, Watanabe K, Ishiura Y, et al. (2002). Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. Br J Clin Pharmacol 54: 622-626.
30. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH, (1995). Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 25 (4 Pt 2): 796-802.
31. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-1110.
32. Rincon M, Irvin CG, (2012). Role of Il-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 8: 1281-1290.
33. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. (1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298-304.
34. Rodrigues-Machado MG, Magalhães GS, Cardoso JA, Kangussu LM, Murari A, Caliari MV, et al. (2013). Ave 0991, a nonpeptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodeling in a model of chronic asthma. Br J Pharmacol 170: 835-846.
35. Santiago NM, Guimarães PS, Sirvente RA, Oliveira LA, Irigoyen MC, Santos RA, et al. (2010). Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling. Hypertension 55: 889-896.
36. Santos CF, Santos SH, Ferreira AV, Botion LM, Santos RA, Campagnole-Santos MJ, (2013). Association of an oral formulation of angiotensin-(1-7) with atenolol improves lipid metabolism in hypertensive rats. Peptides 43: 155-159.
37. Santos RAS, (2014). Angiotensin-(1-7). Hypertension 63: 1138-1147.
38. Schuh J, Blease K, Kunkel S, Hogaboam C, (2003). Chemokines and cytokines: axis and allies in asthma and allergy. Cytokine Growth Factor Rev 14: 503-510.
39. Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, Rennard SL, (1995). Airway inflammation. Ann Intern Med 123: 288-304.
40. Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva RA, Díez-Freire C, Dooies A, et al. (2010). The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 182: 1065-1072.
41. Singh B, Shinagawa K, Taube C, Pabst R, (2005). Strain-specific differences in perivascular inflammation in lungs in two murine models of allergic airway inflammation. Clin Exp Immunol 141: 223-229.
42. Su Z, Zimpelmann J, Burns KD, (2006). Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69: 2212-2218.
43. Tattersfield AE, Knox AJ, Britton JR, Hall IP, (2002). Asthma. Lancet 360: 1313-1322.
44. Temelkovski J, Hogan SP, Shepherd PD, Foster PS, Kumar RK, (1998). An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53: 849-856.
45. Thomas PS, Yates DH, Barnes PJ, (1995). Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 152: 76-80.
46. Tsai M, Chen RH, Tam SY, Blenis J, Galli SJ, (1993). Activation of MAP kinases, pp 90rsk, and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon. Eur J Immunol 23: 3286-3291.
47. Van Wetering S, Zuyderduyn S, Ninaber DK, van Sterkenburg MA, Rabe KF, Hiemstra PS, (2007). Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13. Mol Immunol 44: 803-811.
48. Vieira RP, Claudino RC, Duarte ACS, Santos ABG, Perini A, Faria Neto HCC, et al. (2007). Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice. Am J Respir Crit Care Med 176: 871-877.
49. Wang T, Yin K, Liu K, Lu G, Li YH, Chen J, (2008). Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats. Chin Med J 121: 2312-2319.
50. Wang Y, Qian C, Roks AJ, Westermann D, Schumacher SM, Escher F, et al. (2010). Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circ Heart Fail 3: 286-293.
51. Wilson JW, Li X, Pain MC, (1993). The lack of distensibility of asthmatic airways. Am Rev Respir Dis 148: 806-809.
52. Wong CK, Wang CB, Li ML, Ip WK, Tian YP, Lam CW, (2006). Induction of adhesion molecules upon the interaction between eosinophils and bronchial epithelial cells: involvement of p38 MAPK and NF-kappaB. Int Immunopharmacol 6: 1859-1871.
53. Xisto DG, Farias LL, Ferreira HC, Mauad T, Zin WA, Rocco PRM, (2005). Lung parenchyma remodeling in a murino model of chronic allergic inflammation. Am J Respir Crit Care Med 171: 829-837.
54. Yamamoto H, Sedgwick JB, Busse WW, (1998). Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol 161: 971-977.
55. Zhou X, Hu H, Balzar S, Trudeau JB, Wenzel AS, (2012). MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-b1 and IL-13 in human airway fibroblasts. J Immunol 188: 6046-6054.